Cowen and Company’s Helus Pharma Inc. Common Stock HELP Stock Holding History

Cowen and Company’s Portfolio HELP Stock Details HELP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,579	Closed	-$72K	–	635
2021 Q4	$72K	Buy	+1,579	New	+$100K	0.01%	401

Other funds holding HELP

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

PCC

Perry Creek Capital New York $218M AUM 18.4% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return

EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

TCWP Beachwood, Ohio $40.8M AUM 31.25% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Cowen and Company's HELP Position: Q1 2022 in Review

Cowen and Company sold out of Helus Pharma Inc. Common Stock (HELP) in Q1 2022, closing a stake of 1,579 shares — an estimated $72K sold.

Cowen and Company first reported a position in HELP in Q4 2021 and held it in 1 quarter. The position peaked at $72K in Q4 2021. 51 funds tracked by Wall St. Rank hold HELP as of Q1 2022.

Cowen and Company reported no remaining Helus Pharma Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
Cowen and Company sold 1,579 Helus Pharma Inc. Common Stock shares in Q1 2022, an estimated $72K.
Cowen and Company first reported a position in Helus Pharma Inc. Common Stock in Q4 2021 and held it in 1 quarter.
Cowen and Company's Helus Pharma Inc. Common Stock position peaked at $72K in Q4 2021.
51 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q1 2022.

Based on Cowen and Company's 13F filing for Q1 2022, filed 16 May 2022.